Prophylaxis against fungal peritonitis in CAPD a single center experience with low-dose fluconazole

Renal Failure

Volumn 32, Issue 7, 2010, Pages 802-805

  Prabhu, Mayoor V ^a   Subhramanyam, Sreepada V ^a   Gandhe, Sridhar ^a   Antony, Sinoj K ^a   Nayak, K Shivanand ^a  

^a Global Hospitals   (India)

Author keywords

CAPD; Fluconazole; Fungal peritonitis; Peritonitis; Prophylaxis

Indexed keywords

ANTIBIOTIC AGENT; FLUCONAZOLE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PERITONITIS; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FUNGAL PERITONITIS; HUMAN; INCIDENCE; KIDNEY FAILURE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MYCOSIS; PERITONITIS; PRESCRIPTION; PRIORITY JOURNAL; PROPHYLAXIS; RETROSPECTIVE STUDY; TREATMENT RESPONSE;

ADULT; AGED; ANTIFUNGAL AGENTS; FEMALE; FLUCONAZOLE; HUMANS; MALE; MIDDLE AGED; MYCOSES; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONITIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77954878736     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2010.494797     Document Type: Article

References (22)

1. Chan TM, Lui SL, Li FK, Cheng IK. Fungal peritonitis - Current status 1998. Perit Dial Int. 1999;19(Suppl. 2): S286-S290.
2. The Turkish Multicenter Peritoneal Dialysis Study Group (TULIP). The rate, risk factors, and outcome of fungal peritonitis in CAPD patients: Experience in Turkey. Perit Dial Int. 2000;20(3):338-341.
3. Samonis G, Gikas A, Anaissie EJ, et al. Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans. Antimicrob Agents Chemother. 1993;37:51-53.
4. Piraino B. Peritonitis as a complication of peritoneal dialysis. J Am Soc Nephrol. 1998;9:1956-1964.
5. Eisenberg ES, Leviton I, Soeiro R. Fungal peritonitis in patients receiving peritoneal dialysis: Experience with 11 patients and review of the literature. Rev Infect Dis. 1986;8(3):309-321.
6. Lo HK, Chan CK, Shum HP, Chow VC, Mo KL, Wong KS. Risk factors for poor outcome of fungal peritonitis in Chinese patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 2003;23(Suppl. 2):S123-S126.
7. Prasad KN, Prasad N, Gupta A, Sharma RK, Verma AK, Ayyagari A. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: A single centre Indian experience. J Infect. 2004;48:96-101.
8. Goldie SJ, Kiernan-Tridle L, Torres C, et al. Fungal peritonitis in a large chronic peritoneal dialysis population: A report of 55 episodes. Am J Kidney Dis. 1996;28:86-91.
9. Piraino B, Bailie GR, Bernardini J, et al. Peritoneal dialysisrelated infections recommendations: 2005 update. Perit Dial Int. 2005;25:107-131. (Pubitemid 40484720)
10. Lye W-C. Nystatin prophylaxis for fungal peritonitis: To be or not to be? Perit Dial Int. 2007;27:511-513.
11. Han SH, Lee SC, Ahn SV, et al. Improving outcome of CAPD: Twenty-five years' experience in a single Korean center. Perit Dial Int. 2007;27(4):432-440.
12. Li PK, Law MC, Chow KM, et al. Good patient and technique survival in elderly patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 2007;27(Suppl. 2):S196-S201.
13. Nakamoto H, Kawaguchi Y, Suzuki H. Is technique survival on peritoneal dialysis better in Japan?. Perit Dial Int. 2006;26(2):136-143.
14. Wadhwa NK, Suh H, Cabralda T. Antifungal prophylaxis for secondary fungal peritonitis in peritoneal dialysis patients. Adv Perit Dial. 1996;12:189-191.
15. Zaruba K, Peters J, Jungbluth H. Successful prophylaxis for fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: Six years' experience. Am J Kidney Dis. 1991;27:43-46.
16. Robitaille P, Merouani A, Clermont MJ, Herbert E. Successful antifungal prophylaxis in chronic peritoneal dialysis: A pediatric experience. Perit Dial Int. 1995;15:77-79.
17. Lo WK, Chan CY, Cheng SW, Poon JFM, Chan DTM, Cheng IKP. A prospective randomized control study of oral nystatin prophylaxis for Candida peritoneal dialysis. Am J Kidney Dis. 1996;28:549-552.
18. Williams PF, Moncrief N, Marriott J. No benefits in using nystatin prophylaxis against fungal peritonitis in peritoneal dialysis patients. Perit Dial Int. 2000;20:352-353.
19. Thodis E, Vas SI, Bargman JM, Singhal M, Chu M, Oreopoulos DG. Nystatin prophylaxis: Its inability to prevent fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 1998;18:583-589.
20. Wong PN, Lo KY, Tong GM, et al. Prevention of fungal peritonitis with nystatin prophylaxis in patients receiving CAPD. Perit Dial Int. 2007;27(5):531-536.
21. Moreiras-Plaza M, Vello-Román A, Sampróm-Rodríguez M, Feijóo-Piñeiro D. Ten years without fungal peritonitis: A single center's experience. Perit Dial Int. 2007;27(4): 460-463.
22. Debruyme D, Ryckelynck J-P, Moulin M, Hurault deligny B, Levaltier B, Bigot M-C. Pharmacokinetics of fluconazole in patients undergoing continuous ambulatory peritoneal dialysis. Clin Pharmacokinet. 1990;18:491-498. (Pubitemid 20183891)